Genetic analysis of genes causing hypertension and stroke in spontaneously hypertensive rats: Gene expression profiles in the kidneys
暂无分享,去创建一个
H. Okamura | Hideyuki Yamamoto | T. Yasunaga | H. Nojima | D. Okuzaki | H. Matsunaga | H. Yamanishi | YUKO WATANABE | MOMOKO YOSHIDA | KYOSUKE YAMANISHI | HIDEYUKI YAMAMOTO | DAISUKE OKUZAKI | HIROSHI NOJIMA | TERUO YASUNAGA | HARUKI OKAMURA | HISATO MATSUNAGA | HIROMICHI YAMANISHI | Kyosuke Yamanishi | Yuko Watanabe | Momoko Yoshida
[1] T. Partonen,et al. CREM mutations and ADHD symptoms. , 2009, Medical hypotheses.
[2] C. Férec,et al. Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis , 2001, Clinical genetics.
[3] E. Thomas,et al. Striatal specificity of gene expression dysregulation in Huntington's disease , 2006, Journal of neuroscience research.
[4] Limin Liu,et al. Disruption of the Lecithin:Retinol Acyltransferase Gene Makes Mice More Susceptible to Vitamin A Deficiency* , 2005, Journal of Biological Chemistry.
[5] S. Chattopadhyay,et al. Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element , 2010, The EMBO journal.
[6] D. Viggiano,et al. Involvement of Norepinephrine in the Control of Activity and Attentive Processes in Animal Models of Attention Deficit Hyperactivity Disorder , 2004, Neural plasticity.
[7] M. Schmid,et al. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF , 2000, Oncogene.
[8] J. Harney,et al. Activation of thyroid hormone is transcriptionally regulated by epidermal growth factor in human placenta-derived JEG3 cells. , 2008, Endocrinology.
[9] A. Schroit,et al. Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis. , 2007, The American journal of pathology.
[10] E. Woodcock,et al. UTP Transactivates Epidermal Growth Factor Receptors and Promotes Cardiomyocyte Hypertrophy Despite Inhibiting Transcription of the Hypertrophic Marker Gene, Atrial Natriuretic Peptide* , 2004, Journal of Biological Chemistry.
[11] Sarah J Tabrizi,et al. Gene expression in Huntington's disease skeletal muscle: a potential biomarker. , 2005, Human molecular genetics.
[12] Michael L. Atchison,et al. PU.1 Can Recruit BCL6 to DNA To Repress Gene Expression in Germinal Center B Cells , 2009, Molecular and Cellular Biology.
[13] A. Schroit,et al. Plasmin-Cleaved β-2-Glycoprotein 1 Is an Inhibitor of Angiogenesis , 2007 .
[14] D. Townsend,et al. “Skittish” Abca2 Knockout Mice Display Tremor, Hyperactivity, and Abnormal Myelin Ultrastructure in the Central Nervous System , 2006, Molecular and Cellular Biology.
[15] Mehdi Farshbaf,et al. Rodent Models of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.
[16] B. Spencer‐Dene,et al. c-Jun in Schwann cells promotes axonal regeneration and motoneuron survival via paracrine signaling , 2012, The Journal of cell biology.
[17] F. He,et al. Protein interaction data set highlighted with human Ras-MAPK/PI3K signaling pathways. , 2008, Journal of proteome research.
[18] Gideon Rechavi,et al. Identification of Direct p73 Target Genes Combining DNA Microarray and Chromatin Immunoprecipitation Analyses* , 2002, The Journal of Biological Chemistry.
[19] J. Blangero,et al. A transcriptional profile of the decidua in preeclampsia. , 2011, American journal of obstetrics and gynecology.
[20] D. Denhardt,et al. Osteopontin: role in immune regulation and stress responses. , 2011, Cytokine & growth factor reviews.
[21] Masamichi Ishizaka,et al. In vitro selection of Jun-associated proteins using mRNA display. , 2004, Nucleic acids research.
[22] B. Hollis,et al. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. , 2008, Endocrinology.
[23] S. Umemura,et al. Novel Regulatory Effect of Angiotensin II Type 1 Receptor–Interacting Molecule on Vascular Smooth Muscle Cells , 2007, Hypertension.
[24] P. Hopkins,et al. Ala92 Type 2 Deiodinase Allele Increases Risk for the Development of Hypertension , 2007, Hypertension.
[25] V. de Waard,et al. Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis , 2011, The Journal of experimental medicine.
[26] A. Guyton,et al. Abnormal Renal Function and Autoregulation in Essential Hypertension , 1991, Hypertension.
[27] Nicholas J Schork,et al. Common genetic mechanisms of blood pressure elevation in two independent rodent models of human essential hypertension. , 2005, American journal of hypertension.
[28] L. Luttrell,et al. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. , 2012, Molecular endocrinology.
[29] V. Reghunandanan,et al. Neurotransmitters of the suprachiasmatic nuclei , 2006, Journal of circadian rhythms.
[30] J. Fletcher,et al. Adrenomedullary function during cognitive testing in attention-deficit/hyperactivity disorder. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.
[31] M. Simon,et al. SPI-B Activates Transcription via a Unique Proline, Serine, and Threonine Domain and Exhibits DNA Binding Affinity Differences from PU.1* , 1999, The Journal of Biological Chemistry.
[32] J. Avruch,et al. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.
[33] A. Dominiczak,et al. Genetics of hypertension: From experimental animals to humans , 2010, Biochimica et biophysica acta.
[34] D. Denhardt,et al. Osteopontin: a protein with diverse functions , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] J. Olson,et al. Regional and cellular gene expression changes in human Huntington's disease brain. , 2006, Human molecular genetics.
[36] Albert B. Reynolds,et al. The Catenin p120ctnInteracts with Kaiso, a Novel BTB/POZ Domain Zinc Finger Transcription Factor , 1999, Molecular and Cellular Biology.
[37] R. D. De Lisle,et al. Inflammation of the cystic fibrosis mouse small intestine. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[38] M. Washburn,et al. The SOX2-Interactome in Brain Cancer Cells Identifies the Requirement of MSI2 and USP9X for the Growth of Brain Tumor Cells , 2013, PloS one.
[39] L. Navar,et al. The absence of intrarenal ACE protects against hypertension. , 2013, The Journal of clinical investigation.
[40] M. Minami,et al. Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder , 2002, Behavioural pharmacology.
[41] K. Shimada,et al. Gene expression in the adrenal glands of three spontaneously hypertensive rat substrains. , 2010, Molecular medicine reports.
[42] P. Soubrié,et al. Altered neurotensin mrna expression in mice lacking the dopamine transporter , 2004, Neuroscience.
[43] A. Sabichi,et al. Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth , 2003, Oncogene.
[44] R. D. Rudic,et al. Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection. , 2009, The American journal of pathology.
[45] H. Drexler,et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. , 2006, Circulation research.
[46] H. Okamura,et al. Analysis of genes causing hypertension and stroke in spontaneously hypertensive rats: gene expression profiles in the brain. , 2014, International journal of molecular medicine.
[47] Guosong Qiu,et al. Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages Published, JLR Papers in Press, July 20, 2007. , 2007, Journal of Lipid Research.
[48] Alexander L. Dent,et al. Repression of AP-1 Function: A Mechanism for the Regulation of Blimp-1 Expression and B Lymphocyte Differentiation by the B Cell Lymphoma-6 Protooncogene1 , 2002, The Journal of Immunology.
[49] D. Ambrosetti,et al. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation , 2005, The Journal of cell biology.
[50] J. Chiang,et al. Cytokine regulation of human sterol 12alpha-hydroxylase (CYP8B1) gene. , 2005, American Journal of Physiology - Gastrointestinal and Liver Physiology.
[51] H. Nevanlinna,et al. Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: A report from Finland , 2005, Scandinavian journal of gastroenterology.
[52] K. Sabapathy,et al. c-Jun Regulates the Stability and Activity of the p53 Homologue, p73* , 2004, Journal of Biological Chemistry.
[53] K. Okamoto,et al. Development of a strain of spontaneously hypertensive rats. , 1963, Japanese circulation journal.
[54] L. Cai,et al. Angiotensin II-induced p53-dependent cardiac apoptotic cell death: its prevention by metallothionein. , 2009, Toxicology letters.
[55] L. Zitvogel,et al. Decoding Cell Death Signals in Inflammation and Immunity , 2010, Cell.
[56] J. Cristol,et al. Simvastatin Prevents Angiotensin II–Induced Cardiac Alteration and Oxidative Stress , 2002, Hypertension.
[57] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[58] S. Nishiguchi,et al. Genetic analysis of genes causing hypertension and stroke in spontaneously hypertensive rats. , 2013, International journal of molecular medicine.
[59] J. Chiang,et al. Cytokine regulation of human sterol 12α-hydroxylase (CYP8B1) gene , 2005 .
[60] D. Housman,et al. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[61] G. Kay,et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. , 2000, Circulation research.
[62] T R Butt,et al. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast. , 1996, Molecular endocrinology.
[63] P. D. de Jong,et al. Targeted Disruption of the Idol Gene Alters Cellular Regulation of the Low-Density Lipoprotein Receptor by Sterols and Liver X Receptor Agonists , 2011, Molecular and Cellular Biology.
[64] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[65] R. Roberts,et al. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy , 2003, The EMBO journal.
[66] K. Tomita,et al. Hes1 and Hes3 regulate maintenance of the isthmic organizer and development of the mid/hindbrain , 2001, The EMBO journal.
[67] A. Dominiczak,et al. Functional genomics in rodent models of hypertension , 2004, The Journal of physiology.
[68] R. Maldonado,et al. Altered emotional and locomotor responses in mice deficient in the transcription factor CREM. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[69] Yi Fu,et al. Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo , 2007, Proceedings of the National Academy of Sciences.
[70] T. Nabika,et al. The Stroke-Prone Spontaneously Hypertensive Rat: How Good Is It as a Model for Cerebrovascular Diseases? , 2004, Cellular and Molecular Neurobiology.
[71] Godfrey L. Smith,et al. Overexpression of ryanodine receptor type 1 enhances mitochondrial fragmentation and Ca2+-induced ATP production in cardiac H9c2 myoblasts. , 2013, American journal of physiology. Heart and circulatory physiology.
[72] K. Takeda,et al. Downregulation of Vascular Angiotensin II Type 1 Receptor by Thyroid Hormone , 2003, Hypertension.
[73] E. Wagner,et al. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation , 2000, Nature Genetics.
[74] M. Piascik,et al. The α1D-Adrenergic Receptor Induces Vascular Smooth Muscle Apoptosis via a p53-Dependent Mechanism , 2008, Molecular Pharmacology.
[75] S. De Flora,et al. Gene Expression in the Lung of p53 Mutant Mice Exposed to Cigarette Smoke , 2004, Cancer Research.
[76] K. Okamoto. Establishment of the strokeprone spontaneously hypertensive rat (SHR) , 1972 .
[77] A. Nagaoka,et al. Pathogenesis and prevention of stroke in spontaneously hypertensive rats. , 1975, Clinical science and molecular medicine. Supplement.
[78] B. Nilsson,et al. Activated Platelets Provide a Functional Microenvironment for the Antiangiogenic Fragment of Histidine-Rich Glycoprotein , 2009, Molecular Cancer Research.
[79] S. Faraone,et al. Molecular genetics of attention deficit hyperactivity disorder. , 2010, The Psychiatric clinics of North America.
[80] K. Elenitoba-Johnson,et al. Analysis of BCL6-interacting Proteins by Tandem Mass Spectrometry*S , 2005, Molecular & Cellular Proteomics.
[81] J. Witztum,et al. The role of innate immunity in atherogenesis11 Guest editor for this article was Linda Curtiss, the Scripps Research Institute. Published, JLR Papers in Press, December 22, 2008. , 2009, Journal of Lipid Research.
[82] J. Zavadil,et al. Distinct Functions of Sox2 Control Self-Renewal and Differentiation in the Osteoblast Lineage , 2011, Molecular and Cellular Biology.